Milestone Pharmaceuticals Inc.
MIST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $192,989 | $128,777 | $53,035 | $146,817 |
| - Cash | $46,685 | $42,499 | $45,085 | $25,314 |
| + Debt | $57,208 | $56,394 | $55,587 | $54,797 |
| Enterprise Value | $203,512 | $142,672 | $63,537 | $176,300 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$25 | $0 | $0 | -$567 |
| % Margin | – | – | – | – |
| EBITDA | -$11,003 | -$11,987 | -$19,799 | -$10,942 |
| % Margin | – | – | – | – |
| Net Income | -$11,922 | -$12,966 | -$20,761 | -$12,363 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.2 | -0.31 | -0.2 |
| % Growth | 40% | 35.5% | -55% | – |
| Operating Cash Flow | -$9,816 | -$12,566 | -$13,952 | -$6,843 |
| Capital Expenditures | -$2 | -$11 | -$6 | -$22 |
| Free Cash Flow | -$9,818 | -$12,577 | -$13,958 | -$6,865 |